期刊文献+

脑转移瘤伽玛刀后复发和放射性脑坏死的磁共振灌注成像鉴别诊断 被引量:4

Perfusion-weighted imaging(PWI)in differentiating recurrent brain metastases after gamma knife treatment from delayed cerebral necrosis treatment
暂未订购
导出
摘要 目的:探讨磁共振灌注成像(PWI)对脑转移瘤伽玛刀后复发和放射性脑坏死鉴别诊断价值。方法:21例经伽玛刀治疗的脑转移瘤患者和6例病史明确的放射性脑坏死,均行PWI。结果:前21例经手术证实,18例为脑转移瘤,3例放射性脑坏死,PWI定性诊断正确。18例脑转移瘤的rCBV值均升高,肿瘤最大rCBV比率为6.04±2.86,健侧为3.16±0.93(P<0.01);肿瘤MTT比率为1.49±0.58。9例放射性脑坏死rCBV值均降低,病灶最大rCBV比率为2.02±1.36,健侧为4.30±1.22(P<0.05);病灶MTT比率为1.08±0.14。结论:PWI对脑转移瘤伽玛刀后复发和放射性脑坏死鉴别有重要价值。 Objective:To evaluate perfusion-weighted imaging(PWI)in differentiating recurrent brain metastases after gam-ma knife treatment from delayed cerebral necrosis.Materials and Methods:21patients who had clinical and CT,MRI changes that suggested a diagnosis of delayed cerebral necrosis or recurrent brain metastases after gamma knife treatment and6patients who had a clear clinical diagnosis of delayed cerebral necrosis underwent PWI.Results:Of the former21cases who proved by surgicopathology,18cases were metastases,3cases were delayed cerebral necrosis,their etiologic diagnoses of PWI were correct.PWI in18cases with brain metastases exhibited increased rCBV.The ratios of maximum rCBV of the lesions were6.04±2.86,of the normal sides were3.16±0.93(P<0.01).The ratios of MTT of the tumors were1.49±0.58.PWI in9cases with delayed cerebral necrosis appeared decreased rCBV(P<0.01),the ratios of maximum rCBV of the lesions were2.02±1.36,of the healthy sides were4.30±1.22(P<0.05),The ratios of MTT of the lesions were1.08±0.14.Conclusion:PWI is positively claimed for differentiating recurrent brain metastases after gamma knife treatment from delayed cerebral necrosis.
出处 《中国临床医学影像杂志》 CAS 2003年第5期306-309,共4页 Journal of China Clinic Medical Imaging
关键词 脑肿瘤 肿瘤转移 磁共振成像 brain neoplasms neoplasm metastasis magnetic resonance imaging
  • 相关文献

参考文献8

  • 1[1]Sugahara T, Korogi Y, Kochi M, et al. Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques. AJNR, 2001, 22 (8):1306-1315.
  • 2[2]Cha S, Knopp EA, Johnson G, et al. Dynamic contrastenhanced T2*-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. AJNR, 2000, 21 (5):881-890.
  • 3张红梅,高培毅,胡平英.脑组织血流灌注的动态CT定量研究[J].中华放射学杂志,1999,33(7):448-451. 被引量:31
  • 4[4]Wong JC, Provenzale JM, Petrella JR. Perfusion MR imaging of brain neoplasms. AJR, 2000, 174 (4): 1147-1157.
  • 5[5]Nelson SJ, Nat DR. Imaging of brain tumors after therapy. Neuroimaging Clin North Am, 1999, 9 (4): 801-819.
  • 6[6]Knopp EA, Cha S, Johnson G. et al. Glial neoplasms:dynamic contrast-enhanced T2*-weighted MR imaging. Radiology,1999, 211 (6): 791-798.
  • 7[8]Verstraete KL, Deene YD, Roels A, et al. Benign and malignant musculoskeletal lesions dynamic contrast-enhanced MR imaging-parametric "first-pass" images depict tissue vascularization and perfusion. Radiology, 1994, 192 (3): 835-843.
  • 8董海波,戴嘉中,蔡佩武,沈天真,盛晓芳,潘力,尹士杰.^1H磁共振波谱在胶质瘤放疗后复发和放射性脑坏死鉴别中的初步应用[J].中华放射学杂志,2001,35(6):439-441. 被引量:25

二级参考文献6

共引文献52

同被引文献26

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部